IDYA
Price
$26.84
Change
-$0.08 (-0.30%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
2.35B
33 days until earnings call
PRAX
Price
$54.23
Change
+$2.18 (+4.19%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
1.14B
27 days until earnings call
Interact to see
Advertisement

IDYA vs PRAX

Header iconIDYA vs PRAX Comparison
Open Charts IDYA vs PRAXBanner chart's image
IDEAYA Biosciences
Price$26.84
Change-$0.08 (-0.30%)
Volume$62.36K
Capitalization2.35B
Praxis Precision Medicines
Price$54.23
Change+$2.18 (+4.19%)
Volume$22.74K
Capitalization1.14B
IDYA vs PRAX Comparison Chart in %
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. PRAX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Buy and PRAX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (IDYA: $26.84 vs. PRAX: $54.29)
Brand notoriety: IDYA and PRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 95% vs. PRAX: 102%
Market capitalization -- IDYA: $2.35B vs. PRAX: $1.14B
IDYA [@Biotechnology] is valued at $2.35B. PRAX’s [@Biotechnology] market capitalization is $1.14B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whilePRAX’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • PRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, PRAX is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 5 TA indicator(s) are bullish while PRAX’s TA Score has 7 bullish TA indicator(s).

  • IDYA’s TA Score: 5 bullish, 4 bearish.
  • PRAX’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, PRAX is a better buy in the short-term than IDYA.

Price Growth

IDYA (@Biotechnology) experienced а -1.90% price change this week, while PRAX (@Biotechnology) price change was +2.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.02%. For the same industry, the average monthly price growth was +18.92%, and the average quarterly price growth was +86.47%.

Reported Earning Dates

IDYA is expected to report earnings on Nov 11, 2025.

PRAX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+9.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($2.35B) has a higher market cap than PRAX($1.14B). IDYA YTD gains are higher at: 4.436 vs. PRAX (-29.457). PRAX has higher annual earnings (EBITDA): -271.35M vs. IDYA (-380.2M). IDYA has more cash in the bank: 670M vs. PRAX (301M). PRAX has less debt than IDYA: PRAX (755K) vs IDYA (26.6M). PRAX has higher revenues than IDYA: PRAX (7.77M) vs IDYA (7M).
IDYAPRAXIDYA / PRAX
Capitalization2.35B1.14B206%
EBITDA-380.2M-271.35M140%
Gain YTD4.436-29.457-15%
P/E RatioN/AN/A-
Revenue7M7.77M90%
Total Cash670M301M223%
Total Debt26.6M755K3,523%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
68
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYAPRAX
RSI
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 8 days ago
77%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSCIX14.18N/A
N/A
Cohen & Steers Real Estate Securities C
FSCIX34.97N/A
N/A
Fidelity Advisor Small Cap I
MRCGX28.96N/A
N/A
Meridian Growth C
WFICX15.67N/A
N/A
North Star Small Cap Value Institutional
CMPAX24.71N/A
N/A
Calvert Small/Mid-Cap A